The 2-billion Vaccine Question: How realistic are estimates and what s the current status?
SECTIONS
Share
Synopsis
The Centre’s plan for 2 billion doses of Covid-19 vaccines by year-end depends on a massive ramp-up of production as well as flawless trials, approval and manufacturing of five new vaccines. How realistic are the estimates? In what stages are the new vaccines now?
AP
Amid a shortage of Covid-19 vaccines, which has seen many states suspend inoculation sessions, the Centre on May 13 announced that 2 billion doses would be available by the end of the year. This would be a significant leap from the approximately 80 million doses a month currently available.
Share this article
Share this article
ResearchAndMarkets.com s offering.
Clinical Trials, the most crucial step in drug discovery has never been in the forefront in adopting new technologies and transforming from the conventional protocols.
With the development of AI/ML in the last five years, it has opened up a new horizon for transforming clinical trials. It has been proven that use of AI/ML tools can scan through large volumes of data and provide accurate results within minutes which takes enormous time when performed by humans.
Application of analytical tools help identify trends and patterns that may have been difficult to observe otherwise and provide results in the best possible way.